A Long Term Follow-Up Study for Subjects Who Have Received Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells) (LTFU Study)
Latest Information Update: 01 Apr 2024
At a glance
- Drugs Human glial restricted progenitor cells based therapeutics (Primary)
- Indications Transverse myelitis
- Focus Adverse reactions
- Acronyms LTFU Study
- 07 Feb 2024 Status changed from not yet recruiting to recruiting.
- 14 Dec 2023 New trial record